RNA Transcriptional Profiles for the Diagnosis of Serious Bacterial Infections (SBIs) in Febrile Infants ≤ 60 days old
Sunday, April 24, 2022
1:45 PM – 2:00 PM US MT
Location: Convention Center: Four Seasons Ballroom 4
CE: Enduring CME: 0.25
Publication Number: 2455.4
Prashant Mahajan, University of Michigan Medical School, Ann Arbor, MI, United States; Nathan Kuppermann, University of California, Davis, School of Medicine, Sacramento, CA, United States; Zhaohui Xu, Nationwide Children's Hospital, Columbus, OH, United States; Asuncion Mejias, Nationwide Children's Hospital, Columbus, OH, United States; Charlie Casper, University of Utah School of Medicine, Draper, UT, United States; Octavio Ramilo, Nationwide Children's Hospital, Columbus, OH, United States; the Febrile Infant Working Group of PECARN (HHS and HRSA), University of Michigan Medical School, Ann Arbor, MI, United States
Presenting Author(s)
Prashant Mahajan, MD MPH MBA
Professor of Pediatrics and Emergency Medicine University of Michigan Medical School Ann Arbor, Michigan, United States
Participants should be aware of the following financial/non-financial relationships:
Prashant Mahajan, MD MPH MBA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nathan Kuppermann, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Zhaohui Xu, Ph.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Asuncion Mejias, MD, PhD, MsCS: ● Janssen (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee).
Charlie Casper, PhD: ● Roche (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Octavio Ramilo, MD: ● Adagio (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Lilly (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee). ● Pfizer (Currently Ongoing) (Products/Services: Consultant, Advisory Committee). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee).
the Febrile Infant Working Group of PECARN (HHS and HRSA), n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
